Ultralife(ULBI) - 2025 Q3 - Earnings Call Transcript
UltralifeUltralife(US:ULBI)2025-11-18 14:32

Financial Data and Key Metrics Changes - Consolidated revenues for Q3 2025 totaled $43.4 million, up from $35.7 million in Q3 2024, representing a year-over-year growth [9] - The company reported an operating loss of $1 million, including a one-time adjustment of $1.1 million, resulting in a GAAP net loss of $0.07 per share compared to a net income of $0.3 million, or $0.02 per share, in the previous year [5][15] - Consolidated gross profit increased to $9.6 million, a 10.8% rise from $8.7 million in Q3 2024, but gross margin declined to 22.2% from 24.3% [11][12] Business Line Data and Key Metrics Changes - Revenues from the battery and energy product segment were $39.9 million, up from $32.5 million year-over-year, with a 19% increase in government defense sales [9][10] - Communication systems segment revenues increased by 8.2% to $3.4 million from $3.2 million in the previous year [10] - The sales split between commercial and government defense for the battery business remained stable at 70/30, while the domestic-to-international sales split shifted to 72/28 due to increased domestic shipments [10][11] Market Data and Key Metrics Changes - Total backlog at the end of Q3 was $90.1 million, a 6.5% increase from $84.5 million at the end of Q2 [11] - The commercial-to-government defense sales split on a consolidated basis was 65/35, similar to the previous year's 63/37 [11] Company Strategy and Development Direction - The company is focusing on diversification through M&A and new product development to stabilize and improve profitability [6][8] - A company-wide rebranding initiative is underway to unify the Ultralife brand and enhance market identity [7][18] - The closure of the Calgary facility is expected to yield annual savings of approximately $0.8 million throughout 2026 [12][13] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges with gross margins due to supply chain quality issues but remains optimistic about future growth opportunities [5][25] - The completion of the Electric Chem transition is expected to broaden market opportunities, particularly in oil and gas sectors [17][26] - The company is intensifying efforts to improve gross margins through pricing strategies and lean productivity projects [18][19] Other Important Information - Operating expenses increased by 29.4% year-over-year to $10.6 million, influenced by the inclusion of Electric Chem and one-time costs [12] - The company has reduced debt principal by $4.1 million in the first nine months of 2025, exceeding the required amortization [16] Q&A Session Summary - No questions were raised during the Q&A session, and the call concluded with management expressing anticipation for future discussions [27][28]